0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Cat Vaccines Market Insights, Forecast to 2030
Published Date: December 2024
|
Report Code: QYRE-Auto-10C801
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Cat Vaccines Market Insights Forecast to 2028
BUY CHAPTERS

Global Cat Vaccines Market Insights, Forecast to 2030

Code: QYRE-Auto-10C801
Report
December 2024
Pages:107
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Cat Vaccines Market

A vaccine is a biological preparation that provides active acquired immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism and is often made from weakened or killed forms of the microbe, its toxins, or one of its surface proteins.Cat Vaccines are kins of Vaccines for cats
The global Cat Vaccines market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Cat Vaccines is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Cat Vaccines is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The Europe market for Cat Vaccines is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The global key manufacturers of Cat Vaccines include Bayer Healthcare, Vetoquinol S.A, Boehringer Ingelheim, Ceva, Eli Lilly, Heska Co., Merck Animal Health, Merial (Sanofi) and Virbac, etc. In 2023, the global top five players had a share approximately % in terms of revenue.
Report Covers:
This report presents an overview of global market for Cat Vaccines, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Cat Vaccines, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Cat Vaccines, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Cat Vaccines sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Cat Vaccines market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Cat Vaccines sales, projected growth trends, production technology, application and end-user industry.
Market Segmentation

Scope of Cat Vaccines Market Report

Report Metric Details
Report Name Cat Vaccines Market
Segment by Type
Segment by Application
  • Below 6 Months
  • Above 6 Months
Segment by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Boehringer Ingelheim, Ceva, Eli Lilly, Heska Co., Merck Animal Health, Merial (Sanofi), Virbac, Zoetis (Pfizer)
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Sales (consumption), revenue of Cat Vaccines in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 3: Detailed analysis of Cat Vaccines manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
  • Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
  • Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Cat Vaccines sales, revenue, price, gross margin, and recent development, etc.
  • Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
  • Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 14: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Cat Vaccines Market report?

Ans: The main players in the Cat Vaccines Market are Boehringer Ingelheim, Ceva, Eli Lilly, Heska Co., Merck Animal Health, Merial (Sanofi), Virbac, Zoetis (Pfizer)

What are the Application segmentation covered in the Cat Vaccines Market report?

Ans: The Applications covered in the Cat Vaccines Market report are Below 6 Months, Above 6 Months

What are the Type segmentation covered in the Cat Vaccines Market report?

Ans: The Types covered in the Cat Vaccines Market report are Attenuated Live Vaccines, Conjugate Vaccines, Inactivated Vaccines, Subunit Vaccines, Toxoid Vaccines, DNA Vaccines, Recombinant Vaccines

Recommended Reports

Veterinary Vaccines

Animal-Specific Vaccines

Genetic & Viral Vaccines

1 Study Coverage
1.1 Cat Vaccines Product Introduction
1.2 Market by Type
1.2.1 Global Cat Vaccines Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Attenuated Live Vaccines
1.2.3 Conjugate Vaccines
1.2.4 Inactivated Vaccines
1.2.5 Subunit Vaccines
1.2.6 Toxoid Vaccines
1.2.7 DNA Vaccines
1.2.8 Recombinant Vaccines
1.3 Market by Application
1.3.1 Global Cat Vaccines Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Below 6 Months
1.3.3 Above 6 Months
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Cat Vaccines Sales Estimates and Forecasts 2019-2030
2.2 Global Cat Vaccines Revenue by Region
2.2.1 Global Cat Vaccines Revenue by Region: 2019 VS 2023 VS 2030
2.2.2 Global Cat Vaccines Revenue by Region (2019-2024)
2.2.3 Global Cat Vaccines Revenue by Region (2025-2030)
2.2.4 Global Cat Vaccines Revenue Market Share by Region (2019-2030)
2.3 Global Cat Vaccines Sales Estimates and Forecasts 2019-2030
2.4 Global Cat Vaccines Sales by Region
2.4.1 Global Cat Vaccines Sales by Region: 2019 VS 2023 VS 2030
2.4.2 Global Cat Vaccines Sales by Region (2019-2024)
2.4.3 Global Cat Vaccines Sales by Region (2025-2030)
2.4.4 Global Cat Vaccines Sales Market Share by Region (2019-2030)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Cat Vaccines Sales by Manufacturers
3.1.1 Global Cat Vaccines Sales by Manufacturers (2019-2024)
3.1.2 Global Cat Vaccines Sales Market Share by Manufacturers (2019-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Cat Vaccines in 2023
3.2 Global Cat Vaccines Revenue by Manufacturers
3.2.1 Global Cat Vaccines Revenue by Manufacturers (2019-2024)
3.2.2 Global Cat Vaccines Revenue Market Share by Manufacturers (2019-2024)
3.2.3 Global Top 10 and Top 5 Companies by Cat Vaccines Revenue in 2023
3.3 Global Key Players of Cat Vaccines, Industry Ranking, 2022 VS 2023 VS 2024
3.4 Global Cat Vaccines Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Cat Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Cat Vaccines, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Cat Vaccines, Product Offered and Application
3.8 Global Key Manufacturers of Cat Vaccines, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Cat Vaccines Sales by Type
4.1.1 Global Cat Vaccines Historical Sales by Type (2019-2024)
4.1.2 Global Cat Vaccines Forecasted Sales by Type (2025-2030)
4.1.3 Global Cat Vaccines Sales Market Share by Type (2019-2030)
4.2 Global Cat Vaccines Revenue by Type
4.2.1 Global Cat Vaccines Historical Revenue by Type (2019-2024)
4.2.2 Global Cat Vaccines Forecasted Revenue by Type (2025-2030)
4.2.3 Global Cat Vaccines Revenue Market Share by Type (2019-2030)
4.3 Global Cat Vaccines Price by Type
4.3.1 Global Cat Vaccines Price by Type (2019-2024)
4.3.2 Global Cat Vaccines Price Forecast by Type (2025-2030)
5 Market Size by Application
5.1 Global Cat Vaccines Sales by Application
5.1.1 Global Cat Vaccines Historical Sales by Application (2019-2024)
5.1.2 Global Cat Vaccines Forecasted Sales by Application (2025-2030)
5.1.3 Global Cat Vaccines Sales Market Share by Application (2019-2030)
5.2 Global Cat Vaccines Revenue by Application
5.2.1 Global Cat Vaccines Historical Revenue by Application (2019-2024)
5.2.2 Global Cat Vaccines Forecasted Revenue by Application (2025-2030)
5.2.3 Global Cat Vaccines Revenue Market Share by Application (2019-2030)
5.3 Global Cat Vaccines Price by Application
5.3.1 Global Cat Vaccines Price by Application (2019-2024)
5.3.2 Global Cat Vaccines Price Forecast by Application (2025-2030)
6 US & Canada
6.1 US & Canada Cat Vaccines Market Size by Type
6.1.1 US & Canada Cat Vaccines Sales by Type (2019-2030)
6.1.2 US & Canada Cat Vaccines Revenue by Type (2019-2030)
6.2 US & Canada Cat Vaccines Market Size by Application
6.2.1 US & Canada Cat Vaccines Sales by Application (2019-2030)
6.2.2 US & Canada Cat Vaccines Revenue by Application (2019-2030)
6.3 US & Canada Cat Vaccines Market Size by Country
6.3.1 US & Canada Cat Vaccines Revenue by Country: 2019 VS 2023 VS 2030
6.3.2 US & Canada Cat Vaccines Sales by Country (2019-2030)
6.3.3 US & Canada Cat Vaccines Revenue by Country (2019-2030)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Cat Vaccines Market Size by Type
7.1.1 Europe Cat Vaccines Sales by Type (2019-2030)
7.1.2 Europe Cat Vaccines Revenue by Type (2019-2030)
7.2 Europe Cat Vaccines Market Size by Application
7.2.1 Europe Cat Vaccines Sales by Application (2019-2030)
7.2.2 Europe Cat Vaccines Revenue by Application (2019-2030)
7.3 Europe Cat Vaccines Market Size by Country
7.3.1 Europe Cat Vaccines Revenue by Country: 2019 VS 2023 VS 2030
7.3.2 Europe Cat Vaccines Sales by Country (2019-2030)
7.3.3 Europe Cat Vaccines Revenue by Country (2019-2030)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Cat Vaccines Market Size
8.1.1 China Cat Vaccines Sales (2019-2030)
8.1.2 China Cat Vaccines Revenue (2019-2030)
8.2 China Cat Vaccines Market Size by Application
8.2.1 China Cat Vaccines Sales by Application (2019-2030)
8.2.2 China Cat Vaccines Revenue by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Cat Vaccines Market Size by Type
9.1.1 Asia Cat Vaccines Sales by Type (2019-2030)
9.1.2 Asia Cat Vaccines Revenue by Type (2019-2030)
9.2 Asia Cat Vaccines Market Size by Application
9.2.1 Asia Cat Vaccines Sales by Application (2019-2030)
9.2.2 Asia Cat Vaccines Revenue by Application (2019-2030)
9.3 Asia Cat Vaccines Sales by Region
9.3.1 Asia Cat Vaccines Revenue by Region: 2019 VS 2023 VS 2030
9.3.2 Asia Cat Vaccines Revenue by Region (2019-2030)
9.3.3 Asia Cat Vaccines Sales by Region (2019-2030)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Cat Vaccines Market Size by Type
10.1.1 Middle East, Africa and Latin America Cat Vaccines Sales by Type (2019-2030)
10.1.2 Middle East, Africa and Latin America Cat Vaccines Revenue by Type (2019-2030)
10.2 Middle East, Africa and Latin America Cat Vaccines Market Size by Application
10.2.1 Middle East, Africa and Latin America Cat Vaccines Sales by Application (2019-2030)
10.2.2 Middle East, Africa and Latin America Cat Vaccines Revenue by Application (2019-2030)
10.3 Middle East, Africa and Latin America Cat Vaccines Sales by Country
10.3.1 Middle East, Africa and Latin America Cat Vaccines Revenue by Country: 2019 VS 2023 VS 2030
10.3.2 Middle East, Africa and Latin America Cat Vaccines Revenue by Country (2019-2030)
10.3.3 Middle East, Africa and Latin America Cat Vaccines Sales by Country (2019-2030)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Bayer Healthcare
11.1.1 Bayer Healthcare Company Information
11.1.2 Bayer Healthcare Overview
11.1.3 Bayer Healthcare Cat Vaccines Sales, Price, Revenue and Gross Margin (2019-2024)
11.1.4 Bayer Healthcare Cat Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Bayer Healthcare Recent Developments
11.2 Vetoquinol S.A
11.2.1 Vetoquinol S.A Company Information
11.2.2 Vetoquinol S.A Overview
11.2.3 Vetoquinol S.A Cat Vaccines Sales, Price, Revenue and Gross Margin (2019-2024)
11.2.4 Vetoquinol S.A Cat Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Vetoquinol S.A Recent Developments
11.3 Boehringer Ingelheim
11.3.1 Boehringer Ingelheim Company Information
11.3.2 Boehringer Ingelheim Overview
11.3.3 Boehringer Ingelheim Cat Vaccines Sales, Price, Revenue and Gross Margin (2019-2024)
11.3.4 Boehringer Ingelheim Cat Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Boehringer Ingelheim Recent Developments
11.4 Ceva
11.4.1 Ceva Company Information
11.4.2 Ceva Overview
11.4.3 Ceva Cat Vaccines Sales, Price, Revenue and Gross Margin (2019-2024)
11.4.4 Ceva Cat Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Ceva Recent Developments
11.5 Eli Lilly
11.5.1 Eli Lilly Company Information
11.5.2 Eli Lilly Overview
11.5.3 Eli Lilly Cat Vaccines Sales, Price, Revenue and Gross Margin (2019-2024)
11.5.4 Eli Lilly Cat Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Eli Lilly Recent Developments
11.6 Heska Co.
11.6.1 Heska Co. Company Information
11.6.2 Heska Co. Overview
11.6.3 Heska Co. Cat Vaccines Sales, Price, Revenue and Gross Margin (2019-2024)
11.6.4 Heska Co. Cat Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Heska Co. Recent Developments
11.7 Merck Animal Health
11.7.1 Merck Animal Health Company Information
11.7.2 Merck Animal Health Overview
11.7.3 Merck Animal Health Cat Vaccines Sales, Price, Revenue and Gross Margin (2019-2024)
11.7.4 Merck Animal Health Cat Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Merck Animal Health Recent Developments
11.8 Merial (Sanofi)
11.8.1 Merial (Sanofi) Company Information
11.8.2 Merial (Sanofi) Overview
11.8.3 Merial (Sanofi) Cat Vaccines Sales, Price, Revenue and Gross Margin (2019-2024)
11.8.4 Merial (Sanofi) Cat Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Merial (Sanofi) Recent Developments
11.9 Virbac
11.9.1 Virbac Company Information
11.9.2 Virbac Overview
11.9.3 Virbac Cat Vaccines Sales, Price, Revenue and Gross Margin (2019-2024)
11.9.4 Virbac Cat Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Virbac Recent Developments
11.10 Zoetis (Pfizer)
11.10.1 Zoetis (Pfizer) Company Information
11.10.2 Zoetis (Pfizer) Overview
11.10.3 Zoetis (Pfizer) Cat Vaccines Sales, Price, Revenue and Gross Margin (2019-2024)
11.10.4 Zoetis (Pfizer) Cat Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Zoetis (Pfizer) Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Cat Vaccines Industry Chain Analysis
12.2 Cat Vaccines Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Cat Vaccines Production Mode & Process
12.4 Cat Vaccines Sales and Marketing
12.4.1 Cat Vaccines Sales Channels
12.4.2 Cat Vaccines Distributors
12.5 Cat Vaccines Customers
13 Market Dynamics
13.1 Cat Vaccines Industry Trends
13.2 Cat Vaccines Market Drivers
13.3 Cat Vaccines Market Challenges
13.4 Cat Vaccines Market Restraints
14 Key Findings in The Global Cat Vaccines Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
    Table 1. Global Cat Vaccines Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Table 2. Major Manufacturers of Attenuated Live Vaccines
    Table 3. Major Manufacturers of Conjugate Vaccines
    Table 4. Major Manufacturers of Inactivated Vaccines
    Table 5. Major Manufacturers of Subunit Vaccines
    Table 6. Major Manufacturers of Toxoid Vaccines
    Table 7. Major Manufacturers of DNA Vaccines
    Table 8. Major Manufacturers of Recombinant Vaccines
    Table 9. Global Cat Vaccines Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Table 10. Global Cat Vaccines Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 11. Global Cat Vaccines Revenue by Region (2019-2024) & (US$ Million)
    Table 12. Global Cat Vaccines Revenue by Region (2025-2030) & (US$ Million)
    Table 13. Global Cat Vaccines Revenue Market Share by Region (2019-2024)
    Table 14. Global Cat Vaccines Revenue Market Share by Region (2025-2030)
    Table 15. Global Cat Vaccines Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 16. Global Cat Vaccines Sales by Region (2019-2024) & (K Doses)
    Table 17. Global Cat Vaccines Sales by Region (2025-2030) & (K Doses)
    Table 18. Global Cat Vaccines Sales Market Share by Region (2019-2024)
    Table 19. Global Cat Vaccines Sales Market Share by Region (2025-2030)
    Table 20. Global Cat Vaccines Sales by Manufacturers (2019-2024) & (K Doses)
    Table 21. Global Cat Vaccines Sales Share by Manufacturers (2019-2024)
    Table 22. Global Cat Vaccines Revenue by Manufacturers (2019-2024) & (US$ Million)
    Table 23. Global Cat Vaccines Revenue Share by Manufacturers (2019-2024)
    Table 24. Global Key Players of Cat Vaccines, Industry Ranking, 2022 VS 2023 VS 2024
    Table 25. Cat Vaccines Price by Manufacturers 2019-2024 (USD/Dose)
    Table 26. Global Cat Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 27. Global Cat Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cat Vaccines as of 2023)
    Table 28. Global Key Manufacturers of Cat Vaccines, Manufacturing Base Distribution and Headquarters
    Table 29. Global Key Manufacturers of Cat Vaccines, Product Offered and Application
    Table 30. Global Key Manufacturers of Cat Vaccines, Date of Enter into This Industry
    Table 31. Mergers & Acquisitions, Expansion Plans
    Table 32. Global Cat Vaccines Sales by Type (2019-2024) & (K Doses)
    Table 33. Global Cat Vaccines Sales by Type (2025-2030) & (K Doses)
    Table 34. Global Cat Vaccines Sales Share by Type (2019-2024)
    Table 35. Global Cat Vaccines Sales Share by Type (2025-2030)
    Table 36. Global Cat Vaccines Revenue by Type (2019-2024) & (US$ Million)
    Table 37. Global Cat Vaccines Revenue by Type (2025-2030) & (US$ Million)
    Table 38. Global Cat Vaccines Revenue Share by Type (2019-2024)
    Table 39. Global Cat Vaccines Revenue Share by Type (2025-2030)
    Table 40. Cat Vaccines Price by Type (2019-2024) & (USD/Dose)
    Table 41. Global Cat Vaccines Price Forecast by Type (2025-2030) & (USD/Dose)
    Table 42. Global Cat Vaccines Sales by Application (2019-2024) & (K Doses)
    Table 43. Global Cat Vaccines Sales by Application (2025-2030) & (K Doses)
    Table 44. Global Cat Vaccines Sales Share by Application (2019-2024)
    Table 45. Global Cat Vaccines Sales Share by Application (2025-2030)
    Table 46. Global Cat Vaccines Revenue by Application (2019-2024) & (US$ Million)
    Table 47. Global Cat Vaccines Revenue by Application (2025-2030) & (US$ Million)
    Table 48. Global Cat Vaccines Revenue Share by Application (2019-2024)
    Table 49. Global Cat Vaccines Revenue Share by Application (2025-2030)
    Table 50. Cat Vaccines Price by Application (2019-2024) & (USD/Dose)
    Table 51. Global Cat Vaccines Price Forecast by Application (2025-2030) & (USD/Dose)
    Table 52. US & Canada Cat Vaccines Sales by Type (2019-2024) & (K Doses)
    Table 53. US & Canada Cat Vaccines Sales by Type (2025-2030) & (K Doses)
    Table 54. US & Canada Cat Vaccines Revenue by Type (2019-2024) & (US$ Million)
    Table 55. US & Canada Cat Vaccines Revenue by Type (2025-2030) & (US$ Million)
    Table 56. US & Canada Cat Vaccines Sales by Application (2019-2024) & (K Doses)
    Table 57. US & Canada Cat Vaccines Sales by Application (2025-2030) & (K Doses)
    Table 58. US & Canada Cat Vaccines Revenue by Application (2019-2024) & (US$ Million)
    Table 59. US & Canada Cat Vaccines Revenue by Application (2025-2030) & (US$ Million)
    Table 60. US & Canada Cat Vaccines Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 61. US & Canada Cat Vaccines Revenue by Country (2019-2024) & (US$ Million)
    Table 62. US & Canada Cat Vaccines Revenue by Country (2025-2030) & (US$ Million)
    Table 63. US & Canada Cat Vaccines Sales by Country (2019-2024) & (K Doses)
    Table 64. US & Canada Cat Vaccines Sales by Country (2025-2030) & (K Doses)
    Table 65. Europe Cat Vaccines Sales by Type (2019-2024) & (K Doses)
    Table 66. Europe Cat Vaccines Sales by Type (2025-2030) & (K Doses)
    Table 67. Europe Cat Vaccines Revenue by Type (2019-2024) & (US$ Million)
    Table 68. Europe Cat Vaccines Revenue by Type (2025-2030) & (US$ Million)
    Table 69. Europe Cat Vaccines Sales by Application (2019-2024) & (K Doses)
    Table 70. Europe Cat Vaccines Sales by Application (2025-2030) & (K Doses)
    Table 71. Europe Cat Vaccines Revenue by Application (2019-2024) & (US$ Million)
    Table 72. Europe Cat Vaccines Revenue by Application (2025-2030) & (US$ Million)
    Table 73. Europe Cat Vaccines Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 74. Europe Cat Vaccines Revenue by Country (2019-2024) & (US$ Million)
    Table 75. Europe Cat Vaccines Revenue by Country (2025-2030) & (US$ Million)
    Table 76. Europe Cat Vaccines Sales by Country (2019-2024) & (K Doses)
    Table 77. Europe Cat Vaccines Sales by Country (2025-2030) & (K Doses)
    Table 78. China Cat Vaccines Sales by Type (2019-2024) & (K Doses)
    Table 79. China Cat Vaccines Sales by Type (2025-2030) & (K Doses)
    Table 80. China Cat Vaccines Revenue by Type (2019-2024) & (US$ Million)
    Table 81. China Cat Vaccines Revenue by Type (2025-2030) & (US$ Million)
    Table 82. China Cat Vaccines Sales by Application (2019-2024) & (K Doses)
    Table 83. China Cat Vaccines Sales by Application (2025-2030) & (K Doses)
    Table 84. China Cat Vaccines Revenue by Application (2019-2024) & (US$ Million)
    Table 85. China Cat Vaccines Revenue by Application (2025-2030) & (US$ Million)
    Table 86. Asia Cat Vaccines Sales by Type (2019-2024) & (K Doses)
    Table 87. Asia Cat Vaccines Sales by Type (2025-2030) & (K Doses)
    Table 88. Asia Cat Vaccines Revenue by Type (2019-2024) & (US$ Million)
    Table 89. Asia Cat Vaccines Revenue by Type (2025-2030) & (US$ Million)
    Table 90. Asia Cat Vaccines Sales by Application (2019-2024) & (K Doses)
    Table 91. Asia Cat Vaccines Sales by Application (2025-2030) & (K Doses)
    Table 92. Asia Cat Vaccines Revenue by Application (2019-2024) & (US$ Million)
    Table 93. Asia Cat Vaccines Revenue by Application (2025-2030) & (US$ Million)
    Table 94. Asia Cat Vaccines Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 95. Asia Cat Vaccines Revenue by Region (2019-2024) & (US$ Million)
    Table 96. Asia Cat Vaccines Revenue by Region (2025-2030) & (US$ Million)
    Table 97. Asia Cat Vaccines Sales by Region (2019-2024) & (K Doses)
    Table 98. Asia Cat Vaccines Sales by Region (2025-2030) & (K Doses)
    Table 99. Middle East, Africa and Latin America Cat Vaccines Sales by Type (2019-2024) & (K Doses)
    Table 100. Middle East, Africa and Latin America Cat Vaccines Sales by Type (2025-2030) & (K Doses)
    Table 101. Middle East, Africa and Latin America Cat Vaccines Revenue by Type (2019-2024) & (US$ Million)
    Table 102. Middle East, Africa and Latin America Cat Vaccines Revenue by Type (2025-2030) & (US$ Million)
    Table 103. Middle East, Africa and Latin America Cat Vaccines Sales by Application (2019-2024) & (K Doses)
    Table 104. Middle East, Africa and Latin America Cat Vaccines Sales by Application (2025-2030) & (K Doses)
    Table 105. Middle East, Africa and Latin America Cat Vaccines Revenue by Application (2019-2024) & (US$ Million)
    Table 106. Middle East, Africa and Latin America Cat Vaccines Revenue by Application (2025-2030) & (US$ Million)
    Table 107. Middle East, Africa and Latin America Cat Vaccines Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 108. Middle East, Africa and Latin America Cat Vaccines Revenue by Country (2019-2024) & (US$ Million)
    Table 109. Middle East, Africa and Latin America Cat Vaccines Revenue by Country (2025-2030) & (US$ Million)
    Table 110. Middle East, Africa and Latin America Cat Vaccines Sales by Country (2019-2024) & (K Doses)
    Table 111. Middle East, Africa and Latin America Cat Vaccines Sales by Country (2025-2030) & (K Doses)
    Table 112. Bayer Healthcare Company Information
    Table 113. Bayer Healthcare Description and Major Businesses
    Table 114. Bayer Healthcare Cat Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
    Table 115. Bayer Healthcare Cat Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 116. Bayer Healthcare Recent Developments
    Table 117. Vetoquinol S.A Company Information
    Table 118. Vetoquinol S.A Description and Major Businesses
    Table 119. Vetoquinol S.A Cat Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
    Table 120. Vetoquinol S.A Cat Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 121. Vetoquinol S.A Recent Developments
    Table 122. Boehringer Ingelheim Company Information
    Table 123. Boehringer Ingelheim Description and Major Businesses
    Table 124. Boehringer Ingelheim Cat Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
    Table 125. Boehringer Ingelheim Cat Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 126. Boehringer Ingelheim Recent Developments
    Table 127. Ceva Company Information
    Table 128. Ceva Description and Major Businesses
    Table 129. Ceva Cat Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
    Table 130. Ceva Cat Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 131. Ceva Recent Developments
    Table 132. Eli Lilly Company Information
    Table 133. Eli Lilly Description and Major Businesses
    Table 134. Eli Lilly Cat Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
    Table 135. Eli Lilly Cat Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 136. Eli Lilly Recent Developments
    Table 137. Heska Co. Company Information
    Table 138. Heska Co. Description and Major Businesses
    Table 139. Heska Co. Cat Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
    Table 140. Heska Co. Cat Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 141. Heska Co. Recent Developments
    Table 142. Merck Animal Health Company Information
    Table 143. Merck Animal Health Description and Major Businesses
    Table 144. Merck Animal Health Cat Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
    Table 145. Merck Animal Health Cat Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 146. Merck Animal Health Recent Developments
    Table 147. Merial (Sanofi) Company Information
    Table 148. Merial (Sanofi) Description and Major Businesses
    Table 149. Merial (Sanofi) Cat Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
    Table 150. Merial (Sanofi) Cat Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 151. Merial (Sanofi) Recent Developments
    Table 152. Virbac Company Information
    Table 153. Virbac Description and Major Businesses
    Table 154. Virbac Cat Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
    Table 155. Virbac Cat Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 156. Virbac Recent Developments
    Table 157. Zoetis (Pfizer) Company Information
    Table 158. Zoetis (Pfizer) Description and Major Businesses
    Table 159. Zoetis (Pfizer) Cat Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
    Table 160. Zoetis (Pfizer) Cat Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 161. Zoetis (Pfizer) Recent Developments
    Table 162. Key Raw Materials Lists
    Table 163. Raw Materials Key Suppliers Lists
    Table 164. Cat Vaccines Distributors List
    Table 165. Cat Vaccines Customers List
    Table 166. Cat Vaccines Market Trends
    Table 167. Cat Vaccines Market Drivers
    Table 168. Cat Vaccines Market Challenges
    Table 169. Cat Vaccines Market Restraints
    Table 170. Research Programs/Design for This Report
    Table 171. Key Data Information from Secondary Sources
    Table 172. Key Data Information from Primary Sources
List of Figures
    Figure 1. Cat Vaccines Product Picture
    Figure 2. Global Cat Vaccines Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Cat Vaccines Market Share by Type in 2023 & 2030
    Figure 4. Attenuated Live Vaccines Product Picture
    Figure 5. Conjugate Vaccines Product Picture
    Figure 6. Inactivated Vaccines Product Picture
    Figure 7. Subunit Vaccines Product Picture
    Figure 8. Toxoid Vaccines Product Picture
    Figure 9. DNA Vaccines Product Picture
    Figure 10. Recombinant Vaccines Product Picture
    Figure 11. Global Cat Vaccines Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 12. Global Cat Vaccines Market Share by Application in 2023 & 2030
    Figure 13. Below 6 Months
    Figure 14. Above 6 Months
    Figure 15. Cat Vaccines Report Years Considered
    Figure 16. Global Cat Vaccines Revenue, (US$ Million), 2019 VS 2023 VS 2030
    Figure 17. Global Cat Vaccines Revenue 2019-2030 (US$ Million)
    Figure 18. Global Cat Vaccines Revenue Market Share by Region in Percentage: 2023 Versus 2030
    Figure 19. Global Cat Vaccines Revenue Market Share by Region (2019-2030)
    Figure 20. Global Cat Vaccines Sales 2019-2030 ((K Doses)
    Figure 21. Global Cat Vaccines Sales Market Share by Region (2019-2030)
    Figure 22. US & Canada Cat Vaccines Sales YoY (2019-2030) & (K Doses)
    Figure 23. US & Canada Cat Vaccines Revenue YoY (2019-2030) & (US$ Million)
    Figure 24. Europe Cat Vaccines Sales YoY (2019-2030) & (K Doses)
    Figure 25. Europe Cat Vaccines Revenue YoY (2019-2030) & (US$ Million)
    Figure 26. China Cat Vaccines Sales YoY (2019-2030) & (K Doses)
    Figure 27. China Cat Vaccines Revenue YoY (2019-2030) & (US$ Million)
    Figure 28. Asia (excluding China) Cat Vaccines Sales YoY (2019-2030) & (K Doses)
    Figure 29. Asia (excluding China) Cat Vaccines Revenue YoY (2019-2030) & (US$ Million)
    Figure 30. Middle East, Africa and Latin America Cat Vaccines Sales YoY (2019-2030) & (K Doses)
    Figure 31. Middle East, Africa and Latin America Cat Vaccines Revenue YoY (2019-2030) & (US$ Million)
    Figure 32. The Cat Vaccines Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023
    Figure 33. The Top 5 and 10 Largest Manufacturers of Cat Vaccines in the World: Market Share by Cat Vaccines Revenue in 2023
    Figure 34. Global Cat Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 35. Global Cat Vaccines Sales Market Share by Type (2019-2030)
    Figure 36. Global Cat Vaccines Revenue Market Share by Type (2019-2030)
    Figure 37. Global Cat Vaccines Sales Market Share by Application (2019-2030)
    Figure 38. Global Cat Vaccines Revenue Market Share by Application (2019-2030)
    Figure 39. US & Canada Cat Vaccines Sales Market Share by Type (2019-2030)
    Figure 40. US & Canada Cat Vaccines Revenue Market Share by Type (2019-2030)
    Figure 41. US & Canada Cat Vaccines Sales Market Share by Application (2019-2030)
    Figure 42. US & Canada Cat Vaccines Revenue Market Share by Application (2019-2030)
    Figure 43. US & Canada Cat Vaccines Revenue Share by Country (2019-2030)
    Figure 44. US & Canada Cat Vaccines Sales Share by Country (2019-2030)
    Figure 45. U.S. Cat Vaccines Revenue (2019-2030) & (US$ Million)
    Figure 46. Canada Cat Vaccines Revenue (2019-2030) & (US$ Million)
    Figure 47. Europe Cat Vaccines Sales Market Share by Type (2019-2030)
    Figure 48. Europe Cat Vaccines Revenue Market Share by Type (2019-2030)
    Figure 49. Europe Cat Vaccines Sales Market Share by Application (2019-2030)
    Figure 50. Europe Cat Vaccines Revenue Market Share by Application (2019-2030)
    Figure 51. Europe Cat Vaccines Revenue Share by Country (2019-2030)
    Figure 52. Europe Cat Vaccines Sales Share by Country (2019-2030)
    Figure 53. Germany Cat Vaccines Revenue (2019-2030) & (US$ Million)
    Figure 54. France Cat Vaccines Revenue (2019-2030) & (US$ Million)
    Figure 55. U.K. Cat Vaccines Revenue (2019-2030) & (US$ Million)
    Figure 56. Italy Cat Vaccines Revenue (2019-2030) & (US$ Million)
    Figure 57. Russia Cat Vaccines Revenue (2019-2030) & (US$ Million)
    Figure 58. China Cat Vaccines Sales Market Share by Type (2019-2030)
    Figure 59. China Cat Vaccines Revenue Market Share by Type (2019-2030)
    Figure 60. China Cat Vaccines Sales Market Share by Application (2019-2030)
    Figure 61. China Cat Vaccines Revenue Market Share by Application (2019-2030)
    Figure 62. Asia Cat Vaccines Sales Market Share by Type (2019-2030)
    Figure 63. Asia Cat Vaccines Revenue Market Share by Type (2019-2030)
    Figure 64. Asia Cat Vaccines Sales Market Share by Application (2019-2030)
    Figure 65. Asia Cat Vaccines Revenue Market Share by Application (2019-2030)
    Figure 66. Asia Cat Vaccines Revenue Share by Region (2019-2030)
    Figure 67. Asia Cat Vaccines Sales Share by Region (2019-2030)
    Figure 68. Japan Cat Vaccines Revenue (2019-2030) & (US$ Million)
    Figure 69. South Korea Cat Vaccines Revenue (2019-2030) & (US$ Million)
    Figure 70. China Taiwan Cat Vaccines Revenue (2019-2030) & (US$ Million)
    Figure 71. Southeast Asia Cat Vaccines Revenue (2019-2030) & (US$ Million)
    Figure 72. India Cat Vaccines Revenue (2019-2030) & (US$ Million)
    Figure 73. Middle East, Africa and Latin America Cat Vaccines Sales Market Share by Type (2019-2030)
    Figure 74. Middle East, Africa and Latin America Cat Vaccines Revenue Market Share by Type (2019-2030)
    Figure 75. Middle East, Africa and Latin America Cat Vaccines Sales Market Share by Application (2019-2030)
    Figure 76. Middle East, Africa and Latin America Cat Vaccines Revenue Market Share by Application (2019-2030)
    Figure 77. Middle East, Africa and Latin America Cat Vaccines Revenue Share by Country (2019-2030)
    Figure 78. Middle East, Africa and Latin America Cat Vaccines Sales Share by Country (2019-2030)
    Figure 79. Brazil Cat Vaccines Revenue (2019-2030) & (US$ Million)
    Figure 80. Mexico Cat Vaccines Revenue (2019-2030) & (US$ Million)
    Figure 81. Turkey Cat Vaccines Revenue (2019-2030) & (US$ Million)
    Figure 82. Israel Cat Vaccines Revenue (2019-2030) & (US$ Million)
    Figure 83. GCC Countries Cat Vaccines Revenue (2019-2030) & (US$ Million)
    Figure 84. Cat Vaccines Value Chain
    Figure 85. Cat Vaccines Production Process
    Figure 86. Channels of Distribution
    Figure 87. Distributors Profiles
    Figure 88. Bottom-up and Top-down Approaches for This Report
    Figure 89. Data Triangulation
    Figure 90. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Novocure